FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

Listen to an audio podcast of the January 12, 2022, FDA Drug Safety Communication warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth.

Source: FDA Drug Safety Podcasts - January 24, 2022 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts